4391 - 4400 of 8587 Results
Title
Year
- Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational efforts2017OPENTitle: Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational effortsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 140Issue #: 6Start Page: 1544End Page: 1547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awx107Best OA location URL: https://academic.oup.com/brain/article-pdf/140/6/1544/18186427/awx107.pdfCitation Count: 18
-
OPENTitle: Rab29 activation of the Parkinson's disease‐associated LRRK2 kinaseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 37Issue #: 1Start Page: 1End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.201798099Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.201798099Citation Count: 327
-
OPENTitle: LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 5Start Page: 1509End Page: 1525Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab073Best OA location URL: https://academic.oup.com/brain/article-pdf/144/5/1509/38813669/awab073.pdfCitation Count: 24
- Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)2022OPENTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 10
- Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol2024OPENTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12883-024-03702-3.pdfCitation Count: 5
- Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease2018OPENTitle: Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s diseaseJournal Name: PeerJPublisher: PeerJVol: 6Issue #:Start Page: e5539End Page: e5539Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7717/peerj.5539Best OA location URL: https://peerj.com/articles/5539.pdfCitation Count: 18
- Predicting Parkinson’s disease trajectory using clinical and functional MRI features: A reproduction and replication study2025OPENTitle: Predicting Parkinson’s disease trajectory using clinical and functional MRI features: A reproduction and replication studyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e0317566End Page: e0317566Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0317566Best OA location URL: https://doi.org/10.1371/journal.pone.0317566Citation Count: 0
-
OPENTitle: Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the BrainJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 23Start Page: 4465End Page: 4474Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00641Best OA location URL: https://research.vumc.nl/en/publications/e7a97383-cfe9-4b80-8b7c-80534b007972Citation Count: 22
- Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration2022OPENTitle: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2121609119Best OA location URL: https://escholarship.org/content/qt4pt523rv/qt4pt523rv.pdfCitation Count: 37
- Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes2017OPENTitle: Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging PhenotypesJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 4Start Page: 404End Page: 415.e5Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2017.02.009Best OA location URL: http://www.cell.com/article/S2405471217300534/pdfCitation Count: 113